Correlation Between Inhibikase Therapeutics and Dow Jones
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Dow Jones at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Dow Jones into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Dow Jones Industrial, you can compare the effects of market volatilities on Inhibikase Therapeutics and Dow Jones and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Dow Jones. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Dow Jones.
Diversification Opportunities for Inhibikase Therapeutics and Dow Jones
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Inhibikase and Dow is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Dow Jones Industrial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dow Jones Industrial and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Dow Jones. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dow Jones Industrial has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Dow Jones go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Dow Jones
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to under-perform the Dow Jones. In addition to that, Inhibikase Therapeutics is 10.58 times more volatile than Dow Jones Industrial. It trades about -0.32 of its total potential returns per unit of risk. Dow Jones Industrial is currently generating about 0.42 per unit of volatility. If you would invest 4,239,227 in Dow Jones Industrial on November 2, 2024 and sell it today you would earn a total of 248,986 from holding Dow Jones Industrial or generate 5.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibikase Therapeutics vs. Dow Jones Industrial
Performance |
Timeline |
Inhibikase Therapeutics and Dow Jones Volatility Contrast
Predicted Return Density |
Returns |
Inhibikase Therapeutics
Pair trading matchups for Inhibikase Therapeutics
Dow Jones Industrial
Pair trading matchups for Dow Jones
Pair Trading with Inhibikase Therapeutics and Dow Jones
The main advantage of trading using opposite Inhibikase Therapeutics and Dow Jones positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Dow Jones can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dow Jones will offset losses from the drop in Dow Jones' long position.Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Dow Jones vs. Boston Properties | Dow Jones vs. Suntory Beverage Food | Dow Jones vs. Envista Holdings Corp | Dow Jones vs. Fevertree Drinks Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |